News from kindred biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 03, 2014, 16:01 ET

KindredBio Announces Update on AtoKin and Atopic Dermatitis Program

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Nov 17, 2014, 08:30 ET

KindredBio to Present at Jefferies 2014 Global London Healthcare Conference

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced...

Nov 13, 2014, 16:01 ET

Kindred Biosciences Announces Third Quarter 2014 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended September 30, 2014.   KindredBio today...

Nov 06, 2014, 09:02 ET

Kindred Bio to Announce Third Quarter 2014 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it...

Aug 20, 2014, 16:01 ET

Kindred Biosciences Announces Top-Line Results from Pivotal Study of CereKin in Dogs with Osteoarthritis

Kindred Biosciences, Inc. (KindredBio, NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today...

Aug 13, 2014, 16:01 ET

Kindred Biosciences Announces Second Quarter 2014 Financial Results

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended June 30, 2014. Conference Call and Webcast...

Aug 06, 2014, 09:02 ET

KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data

 Kindred Biosciences, Inc. (KindredBio, NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced...

Jun 11, 2014, 09:01 ET

Kindred Bio to Host Investor Breakfast on June 13 in New York City

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

May 21, 2014, 16:01 ET

Kindred Bio to Present at Craig-Hallum, Stifel, and Jefferies Conferences

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...

May 12, 2014, 16:01 ET

Kindred Biosciences Announces First Quarter 2014 Financial Results and Completion of Enrollment in CereKin Pivotal Study

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended March 31, 2014. In addition, Kindred Bio...

May 06, 2014, 09:03 ET

Kindred Bio to Announce First Quarter 2014 Financial Results on Monday, May 12th

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it...

Apr 08, 2014, 16:01 ET

Kindred Bio Announces Closing of Public Offering and Exercise of Over-Allotment Option

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the closing...

Apr 04, 2014, 09:03 ET

Kindred Bio to Present at Needham 13th Annual Healthcare Conference

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Apr 03, 2014, 09:03 ET

Kindred Bio Announces Pricing of Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing...

Mar 31, 2014, 16:09 ET

Kindred Bio Announces Launch of Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the...

Mar 31, 2014, 09:03 ET

Kindred Bio and X-Body Announce an Exclusive Collaboration for Discovery of Antibodies for Companion Animal Health

 Kindred Biosciences, Inc. (NASDAQ: KIN) and X-Body Biosciences (X-Body) jointly announced today an exclusive alliance in which X-Body will...

Mar 28, 2014, 09:03 ET

Kindred Bio Announces Initiation of Pivotal Clinical Study for SentiKin™ in Dogs

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Mar 24, 2014, 09:10 ET

Kindred Bio Appoints Dr. Blake Hawley as Chief Commercial Officer, Announces Upcoming Inclusion in Russell 2000

Kindred Biosciences, Inc. (NASDAQ: KIN) announced today that it has appointed Blake Hawley, D.V.M., as its Chief Commercial Officer. Separately, it...

Mar 18, 2014, 17:09 ET

Kindred Bio Announces Proposed Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has...

Mar 06, 2014, 08:00 ET

Kindred Biosciences Announces Fourth Quarter and Year End 2013 Financial Results

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the fourth quarter and year ended December 31, 2013. Kindred...